Foundation to Fight H-ABC BLOG

Karen B. Karen B.

Rare Disease Is Not Small — It Is a System Hiding in Plain Sight

Rare disease is not defined by numbers alone. It is a shared system shaped by delayed diagnosis, limited data, and under-built infrastructure — challenges experienced every day by families affected by H-ABC Leukodystrophy. Recognizing this reality changes how progress is made.

Read More
Michele Sloan Michele Sloan

The Bridge

The Bridge: For a long time, the story of rare disease was told through the lens of 'scarcity'—too few patients, too much risk, and not enough funding. But we are witnessing a historic pivot. We are moving from an era of managing symptoms to an era of 'curing the incurable.’

Read More
Karen B. Karen B.

Giving Tuesday & the Fight Against H-ABC: Why Your Gift Matters

Each year, Giving Tuesday offers a global pause—an opportunity to come together, to give, and to make an impact. For rare disease foundations like ours, this day does more than raise funds—it raises visibility, strengthens community, and accelerates progress.

Read More
Michele Sloan Michele Sloan

Fall Wins for the H-ABC Community: Progress, People & Momentum

As we approach the end of October, we’re taking a moment to reflect on the incredible momentum our community has built this fall. From fundraising success to scientific progress to new leadership in our advisory team, this season has reminded us of the power of hope, collaboration, and determination. Every step forward is a step we take together- and this fall, we took some big ones.

Read More
Michele Sloan Michele Sloan

Foundation to Fight H-ABC Welcomes Two Leading Experts to Advisory Team

The Foundation to Fight H-ABC is thrilled to announce the addition of Dr. Eric Mallack and Dr. Josh Bonkowsky to our Advisory Board. These two world-renowned experts bring critical expertise in clinical care, neurogenetics, and leukodystrophy research, strengthening our mission to advance understanding and treatment of H-ABC.

Read More
Michele Sloan Michele Sloan

Take Action: Support Renewal of the Rare Pediatric Disease Priority Review Voucher (PRV)

Synaptix Bio urgently needs your support to renew the Priority Review Voucher (PRV) program, a vital tool that provides financial incentives to accelerate clinical trials and speed up the FDA review process here in the U.S.

The PRV program was expected to be extended by Congress last December but remains unapproved due to other legislative priorities. Your voice can help change that.

https://everylifefoundation.org/rare-advocates/take-action/

Read More
link to archived posts